Ioversol Injection
Last Updated: June 12, 2017
Status: Current
Ioversol Injection
-
Ioversol Injection (51%)
Optiray 240 solution for injection, Guerbet
50 mL vial, 25 count (NDC 00019-1324-06)
Optiray 300 solution for injection, Guerbet
50 mL Hand Held prefilled syringe, 20 count (NDC 00019-1332-78)
Optiray 320 solution for injection, Guerbet
20 mL vial, 25 count (NDC 00019-1323-02)
Optiray 350 solution for injection, Guerbet
50 mL prefilled syringe, 20 count (NDC 00019-1333-52)
500 mL pharmacy bulk pack, multi-dose bottle, 6 count (NDC 00019-1333-61)
-
Guerbet could not provide a reason for the Optiray shortage.
-
Ioversol Injection (64%)
Optiray 300 solution for injection, Guerbet
50 mL vial, 25 count (NDC 00019-1332-06)
Ioversol Injection (68%)
Optiray 320 solution for injection, Guerbet
30 mL vial, 25 count (NDC 00019-1323-04)
50 mL Hand Held prefilled syringe, 20 count (NDC 00019-1323-78)
75 mL RFID technology prefilled syringe (NDC 00019-1323-85)
100 mL RFID technology prefilled syringe (NDC 00019-1323-00)
125 mL RFID technology prefilled syringe (NDC 00019-1323-27)
Optiray 350 solution for injection, Guerbet
50 mL Hand Held prefilled syringe, 20 count (NDC 00019-1333-78)
125 mL RFID technology prefilled syringe (NDC 00019-1333-27)
Estimated Resupply Dates
-
Guerbet had most Optiray products on allocation. However, the company did not provide updated availability information.
Updated
June 12, May 2, March 20, February 7, 2017; December 12, November 1, October 13, 2016, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.
